Starting survivorship care before or early in cancer treatment is linked to better survival and lower recurrence in head and neck cancer, according to a University of Pittsburgh study published on October 22, 2026, in JAMA Otolaryngology-Head and Neck Surgery. The finding challenges the usual practice of beginning survivorship care only after treatment ends.
According to the University of Pittsburgh Medical Center, the study followed 471 head and neck cancer patients treated through UPMC Hillman Cancer Center, 148 of whom received early survivorship care before or early in radiotherapy. HealthDay, reporting the study on October 26, 2026, says early care was associated with a 38 percent lower risk of recurrence.
Early-care patients were also about half as likely to miss or stop radiation therapy, according to HealthDay, and the associations with lower three-year recurrence and death held even after accounting for treatment adherence. The study's senior researcher, Marci Lee Nilsen, director of the UPMC Head and Neck Cancer Survivorship Clinic, said the results suggest survivorship support should be woven into treatment from the start rather than added afterwards.
Survivorship care typically covers managing side effects, nutrition, speech and swallowing support, mental health and monitoring for recurrence. According to UPMC, bringing that support forward may help patients complete demanding treatment and recover more fully, although the study reports an association in one patient population rather than proof that early care alone causes the better outcomes.
What happens next is a question for cancer centres: whether to move survivorship services earlier in the treatment pathway and whether the pattern holds in other cancer types and larger, more diverse patient groups.
Image: Dietmar Rabich, CC BY-SA 4.0, via Wikimedia Commons